Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double‐Blind, Phase 3 Trial in China
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Jia Sun, Yu Wang, Yongjing Cheng, Dongmei Guo, Jiankang Hu, Dongzhou Liu, Zhengnan Gao, Changgui Li, Yibing Lu, Xiaodan Kong, Yu Liu, Zhenyu Jiang, Bin Yi, Hongfeng Zhang, Baijie Xu, Shihao Yu, Rieko Kokan, Kohei Ishikawa, Mikiko Kawakatsu, Zhuoli Zhang |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis
by: Wenyan Sun, et al.
Published: (2026)
by: Wenyan Sun, et al.
Published: (2026)
Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout
by: Han Qi, et al.
Published: (2024)
by: Han Qi, et al.
Published: (2024)
The Gut Microbiome in Hyperuricemia and Gout
by: Robert Terkeltaub, et al.
Published: (2025)
by: Robert Terkeltaub, et al.
Published: (2025)
Gout Flares as Vascular Red Flags
by: Mariano Andrés
Published: (2024)
by: Mariano Andrés
Published: (2024)
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”
Published: (2025)
Published: (2025)
Importance of Considering the Gout Flare: Let's Learn to Walk and Chew Gum at the Same Time in Gout Clinical Trial Design
by: Lisa K. Stamp, et al.
Published: (2025)
by: Lisa K. Stamp, et al.
Published: (2025)
Revisiting the Ethics of Urate‐Lowering Therapy Clinical Trials for Gout Management
by: Lisa K. Stamp, et al.
Published: (2026)
by: Lisa K. Stamp, et al.
Published: (2026)
Relation of Colchicine to Total Joint Arthroplasty Among People With Gout in a Population‐Based Cohort Study
by: Zhiqiang Wang, et al.
Published: (2026)
by: Zhiqiang Wang, et al.
Published: (2026)
Weight Loss After Receiving Anti‐Obesity Medications and Gout Among Individuals With Overweight and Obese: A Population‐Based Cohort Study
by: Jie Wei, et al.
Published: (2024)
by: Jie Wei, et al.
Published: (2024)
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti‐Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout
by: Michael H. Pillinger, et al.
Published: (2025)
by: Michael H. Pillinger, et al.
Published: (2025)
Serum Urate Levels Alter the Spatial Distribution of Urate Crystals in Synovium and Correlate With Synovitis and Pain in Non‐Gout Female Patients With Anteromedial Knee Osteoarthritis
by: Hao Xu, et al.
Published: (2025)
by: Hao Xu, et al.
Published: (2025)
Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long‐Term Multicenter Observational Study
by: Takafumi Aritomi, et al.
Published: (2026)
by: Takafumi Aritomi, et al.
Published: (2026)
Regulatory Role of FGL ‐1 in Interorgan Communication by Controlling T Cell Homeostasis During the Onset of Sjögren Disease
by: Kunihiro Otsuka, et al.
Published: (2025)
by: Kunihiro Otsuka, et al.
Published: (2025)
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
by: Tali Eviatar, et al.
Published: (2025)
by: Tali Eviatar, et al.
Published: (2025)
Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain
by: Walter P. Maksymowych, et al.
Published: (2024)
by: Walter P. Maksymowych, et al.
Published: (2024)
Targeting long noncoding RNA H19 in subchondral bone osteocytes for alleviating cartilage degradation in osteoarthritis; comment on the article by Wang et al
by: Suqi Wu, et al.
Published: (2025)
by: Suqi Wu, et al.
Published: (2025)
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
by: Joanna Kedra, et al.
Published: (2024)
by: Joanna Kedra, et al.
Published: (2024)
Global burden of osteoarthritis attributable to high body mass index, 1990 to 2021: insights from the Global Burden of Disease study 2021: comment on the article by Lu et al
by: Bi‐Yu Gao, et al.
Published: (2025)
by: Bi‐Yu Gao, et al.
Published: (2025)
CD177+neutrophils promote endothelial senescence through extracellular traps in Behçet's Disease
by: Xiaoou Wang, et al.
Published: (2026)
by: Xiaoou Wang, et al.
Published: (2026)
Reply
by: Jinjian Fu, et al.
Published: (2026)
by: Jinjian Fu, et al.
Published: (2026)
Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis
by: Min Li, et al.
Published: (2026)
by: Min Li, et al.
Published: (2026)
Associations of fire smoke and other pollutants with incident rheumatoid arthritis and rheumatoid arthritis–associated interstitial lung disease: comment on the article by Kronzer et al
by: Gang Wang, et al.
Published: (2025)
by: Gang Wang, et al.
Published: (2025)
OGFRL1 Deficiency Causes Chronic Recurrent Multifocal Osteomyelitis Via Pathologic Osteoclastogenesis, With Therapeutic Response to Tumor Necrosis Factor Inhibitor
by: Wen Xiong, et al.
Published: (2026)
by: Wen Xiong, et al.
Published: (2026)
Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
by: Brian Meng‐Hsun Li, et al.
Published: (2026)
by: Brian Meng‐Hsun Li, et al.
Published: (2026)
A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease–Like Autoinflammatory Syndrome
by: Longfang Chen, et al.
Published: (2026)
by: Longfang Chen, et al.
Published: (2026)
Doctor versus artificial intelligence: patient and physician evaluation of large language model responses to rheumatology patient questions: comment on the article by Ye et al
by: Gang Wang, et al.
Published: (2024)
by: Gang Wang, et al.
Published: (2024)
The effect of air pollution and genetic susceptibility on systemic lupus erythematosus: comment on the article by Xing et al
by: Na Wang, et al.
Published: (2024)
by: Na Wang, et al.
Published: (2024)
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
by: Zichang Liu, et al.
Published: (2025)
by: Zichang Liu, et al.
Published: (2025)
Efficacy and safety of SGLT2 inhibitors in preventing cardiovascular and renal events in patients with systemic lupus erythematosus and type 2 diabetes: comment on the article by Ma et al
by: Zichang Liu, et al.
Published: (2025)
by: Zichang Liu, et al.
Published: (2025)
Linezolid‐mediated Prevention of Fibroblast Activation and Tissue Fibrosis via Mitochondrial Translation Inhibition
by: Xuezhi Hong, et al.
Published: (2026)
by: Xuezhi Hong, et al.
Published: (2026)
Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations
by: Jinjian Fu, et al.
Published: (2026)
by: Jinjian Fu, et al.
Published: (2026)
Balancing weight reduction benefits and risks: implications for serum urate management. Comment on the article by Fukui et al
by: Pei Liu, et al.
Published: (2025)
by: Pei Liu, et al.
Published: (2025)
Chitinase 3–Like 1 Promotes Endothelial‐to‐Mesenchymal Transition in Systemic Sclerosis via Mechanistic Target of Rapamycin Complex 1 Signaling Pathway
by: Xiuyuan Wang, et al.
Published: (2025)
by: Xiuyuan Wang, et al.
Published: (2025)
Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis
by: Rongliang Wang, et al.
Published: (2025)
by: Rongliang Wang, et al.
Published: (2025)
Mitochondrial Control of Proteasomal Psmb5 Drives the Differentiation of Tissue‐Resident Memory T Cells in Patients with Rheumatoid Arthritis
by: Tong Wu, et al.
Published: (2024)
by: Tong Wu, et al.
Published: (2024)
The recurrence risk in pediatric noninfectious uveitis during adalimumab tapering: are we rigorous enough?
by: Xiuwen Wang, et al.
Published: (2025)
by: Xiuwen Wang, et al.
Published: (2025)
First‐Year IgG Dynamics in IgG4 ‐Related Disease: A Critical Window for Predicting Long‐Term Outcomes
by: Xin He, et al.
Published: (2026)
by: Xin He, et al.
Published: (2026)
Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis
by: Rong Fu, et al.
Published: (2025)
by: Rong Fu, et al.
Published: (2025)
Toll‐Like Receptor 8 is a Therapeutic Target in Rheumatoid Arthritis
by: Yilan Guo, et al.
Published: (2026)
by: Yilan Guo, et al.
Published: (2026)
Reassessing biomarker signatures in RA‐ILD and the impact of gender, environment, and disease activity: comment on the article by Wheeler et al
by: Bi‐yun Yao, et al.
Published: (2025)
by: Bi‐yun Yao, et al.
Published: (2025)
Similar Items
-
A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis
by: Wenyan Sun, et al.
Published: (2026) -
Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout
by: Han Qi, et al.
Published: (2024) -
The Gut Microbiome in Hyperuricemia and Gout
by: Robert Terkeltaub, et al.
Published: (2025) -
Gout Flares as Vascular Red Flags
by: Mariano Andrés
Published: (2024) -
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”
Published: (2025)